1889 Stock Overview
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacturing, marketing, and selling of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.058 |
| 52 Week High | HK$0.12 |
| 52 Week Low | HK$0.051 |
| Beta | 1.06 |
| 1 Month Change | -15.94% |
| 3 Month Change | -17.14% |
| 1 Year Change | -31.76% |
| 3 Year Change | n/a |
| 5 Year Change | -86.19% |
| Change since IPO | -97.04% |
Recent News & Updates
Shareholder Returns
| 1889 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -1.7% | 3.9% | -1.5% |
| 1Y | -31.8% | -4.1% | 3.0% |
Return vs Industry: 1889 underperformed the Hong Kong Pharmaceuticals industry which returned -4.1% over the past year.
Return vs Market: 1889 underperformed the Hong Kong Market which returned 3% over the past year.
Price Volatility
| 1889 volatility | |
|---|---|
| 1889 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 14.2% |
| 10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 1889 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: 1889's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 71 | n/a | https://www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacturing, marketing, and selling of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products and pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
| 1889 fundamental statistics | |
|---|---|
| Market Cap | HK$182.98m |
| Earnings (TTM) | HK$39.33m |
| Revenue (TTM) | HK$194.17m |
4.7x
P/E Ratio1.0x
P/S RatioIs 1889 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1889 income statement (TTM) | |
|---|---|
| Revenue | CN¥181.13m |
| Cost of Revenue | CN¥99.66m |
| Gross Profit | CN¥81.47m |
| Other Expenses | CN¥44.78m |
| Earnings | CN¥36.69m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 44.98% |
| Net Profit Margin | 20.26% |
| Debt/Equity Ratio | 23.0% |
How did 1889 perform over the long term?
See historical performance and comparison